NextPlat (NASDAQ:NXPL – Get Free Report) released its earnings results on Wednesday. The company reported ($0.08) earnings per share for the quarter, FiscalAI reports. The business had revenue of $13.75 million for the quarter. NextPlat had a negative net margin of 17.64% and a negative return on equity of 39.24%.
NextPlat Stock Down 0.4%
Shares of NXPL stock traded down $0.00 on Friday, hitting $0.67. The company’s stock had a trading volume of 166,231 shares, compared to its average volume of 349,849. The stock has a market capitalization of $17.47 million, a price-to-earnings ratio of -1.53 and a beta of 1.11. NextPlat has a fifty-two week low of $0.43 and a fifty-two week high of $2.30. The firm’s fifty day moving average price is $0.80 and its 200-day moving average price is $0.73. The company has a debt-to-equity ratio of 0.05, a current ratio of 4.33 and a quick ratio of 3.49.
Institutional Trading of NextPlat
A hedge fund recently bought a new stake in NextPlat stock. Simplicity Wealth LLC acquired a new stake in shares of NextPlat Corp. (NASDAQ:NXPL – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 600,000 shares of the company’s stock, valued at approximately $497,000. Simplicity Wealth LLC owned about 2.31% of NextPlat as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 1.30% of the company’s stock.
Wall Street Analyst Weigh In
Get Our Latest Research Report on NXPL
About NextPlat
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
Read More
- Five stocks we like better than NextPlat
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Fiserv Has NEVER Done This Before—Is It a Screaming Buy?
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since
- What is the Nikkei 225 index?
- Here’s What We Learned From AST SpaceMobile’s Q3 Earnings Report
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
